These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25911789)

  • 1. [Application of multicomponent dissolution evaluation method of biopharmaceutics classification system of Chinese materia medica in gegen qinlian tablets].
    Wei L; Wang GP; Dong L; Tang MM; Zhang L; Zhu ML; Liu Y
    Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(23):4494-8. PubMed ID: 25911789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on biopharmaceutics classification system of Chinese materia medica for Gegen Qinlians Tablets based on anti-inflammatory activity].
    Wang ZY; Liu Y; Zhang X; Li YP; Cheng YR; Dong L
    Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(17):3662-3671. PubMed ID: 31602938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impacts of multicomponent environment on intrinsic dissolution rate of berberine in biopharmaceutics classification system of Chinese materia medica].
    Yin XW; Wang ZY; Pan M; Zhang X; Wang J; Li YP; Dong L
    Zhongguo Zhong Yao Za Zhi; 2018 Jun; 43(11):2269-2273. PubMed ID: 29945378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of multicomponent environment on intestinal permeability of puerarin in biopharmaceutics classification system of Chinese materia medica].
    Liu Y; Wang G; Dong L; Tang MM; Zhu ML; Dong HH; Hou CB
    Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(23):4505-8. PubMed ID: 25911791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impacts of multicomponent environment on solubility of puerarin in biopharmaceutics classification system of Chinese materia medica].
    Hou CB; Wang GP; Zhang Q; Yang WN; Lv BR; Wei L; Dong L
    Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(23):4499-504. PubMed ID: 25911790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biopharmaceutics classification system of Chinese materia medica of berberine in Gegen Qinlian decoction].
    Liu Y; Zhu ML; Sun HJ; Wang ZY; Chen JP; Dong YL; Dong L
    Zhongguo Zhong Yao Za Zhi; 2017 Apr; 42(8):1545-1550. PubMed ID: 29071860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Research on attributes of biopharmaceutics classification system for Chinese materia medica of baicalein in Gegen Qinlian Decoction environment].
    Liu Y; Yang L; Zhang X; Cheng YR; Gong YT; Dong L
    Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(17):3653-3661. PubMed ID: 31602937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Construction of biopharmaceutics classification system of Chinese materia medica].
    Liu Y; Wei L; Dong L; Zhu ML; Tang MM; Zhang L
    Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(23):4479-83. PubMed ID: 25911786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research and development thought on biopharmaceutics classification system of Chinese materia medica].
    Liu Y; Wang ZY; Xu WJ; Zhang CJ; Dong L
    Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(17):3637-3644. PubMed ID: 31602935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on biopharmaceutics classification system for Chinese materia medica of extract of Huanglian].
    Liu Y; Yin XW; Wang ZY; Li XL; Pan M; Li YP; Dong L
    Zhongguo Zhong Yao Za Zhi; 2017 Nov; 42(21):4127-4134. PubMed ID: 29271150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of attribution of multicomponent original medicinal materials in gegen qinlian decoction with intestinal permeability].
    Zhu ML; Yang WN; Dong L; Dong HH; Hou CB; Liu Y
    Zhongguo Zhong Yao Za Zhi; 2014 Dec; 39(23):4489-93. PubMed ID: 25911788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on property of biopharmaceutics classification system of berberine in Huanglian decoction].
    Wei L; Zhu ML; Dong YL; Dong L; Liu Y; Chen JP; Yin XW
    Zhongguo Zhong Yao Za Zhi; 2016 Apr; 41(7):1192-1197. PubMed ID: 28879730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of puerarin in gegen ginlian tablets by RP-HPLC].
    Tan S; Qiu X; Li G; Zhao B; Liang Y
    Zhongguo Zhong Yao Za Zhi; 1996 Dec; 21(12):732-3, 761-2. PubMed ID: 9812678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous analysis of nine active components in Gegen Qinlian preparations by high-performance liquid chromatography with diode array detection.
    Chen L; Wang Q; Liu J
    J Sep Sci; 2006 Sep; 29(14):2203-10. PubMed ID: 17069251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro dissolution rate of Liuwei Wuling tablet based on biological potency and integrated dissolution].
    Zheng J; Cheng L; Shen CY; Li JJ; Qiu L; Shen G; Han J; Yuan HL
    Zhongguo Zhong Yao Za Zhi; 2015 Nov; 40(22):4395-9. PubMed ID: 27097413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adscription of plasma effective constituents of rat after oral administration of gegen qinlian decoction].
    Jin H; Wang Y; Yan C
    Zhongguo Zhong Yao Za Zhi; 2008 Nov; 33(22):2687-91. PubMed ID: 19216173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biopharmaceutics classification of puerarin and comparison of perfusion approaches in rats.
    Li H; Dong L; Liu Y; Wang G; Wang G; Qiao Y
    Int J Pharm; 2014 May; 466(1-2):133-8. PubMed ID: 24607203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [An in vitro analytical method based on bio-thermal activity for the determination of dissolution rate of Chinese medicine solid preparation].
    Huang X; Yuan HL; Xiao XH; Zhang TT
    Yao Xue Xue Bao; 2010 Mar; 45(3):338-42. PubMed ID: 21351510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folic acid: a biopharmaceutical evaluation.
    Bellavinha KR; Silva-Barcellos NM; Souza JB; Leite JC; Souza Jd
    Pharm Dev Technol; 2015; 20(6):730-7. PubMed ID: 24867254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Evaluation of Valsartan Biopharmaceutics Properties.
    de Castro LML; de Souza J; Caldeira TG; de Carvalho Mapa B; Soares AFM; Pegorelli BG; Della Croce CC; Barcellos NMS
    Curr Drug Res Rev; 2020; 12(1):52-62. PubMed ID: 31820707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.